📣 VC round data is live. Check it out!
- Public Comps
- Exosens
Exosens Valuation Multiples
Discover Exosens' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Carel Industries, nLight, MITAC Holdings, RORZE and more.
Exosens Overview
About Exosens
Exosens SA is a high-tech company specializing in electro-optical technologies for amplification, detection, and imaging. It offers products such as night vision tubes, ultraviolet cameras, travelling wave tubes, and various detectors for defense, life sciences, nuclear, and industrial sectors. With multiple production sites in Europe and North America. The company’s activities are organized into two main segments: Amplification, which focuses on electron or electromagnetic wave amplification systems mainly used in defense night vision equipment and generates the majority of its revenue, and Detection & Imaging, which provides high value-added components for commercial markets such as nuclear power, research, and industrial applications.
Founded
2021
HQ

Employees
1.8K
Website
Financials (LTM)
EV
$4B
Valuation Multiples
Start free trialExosens Financials
Exosens reported last 12-month revenue of $582M and EBITDA of $189M.
In the same LTM period, Exosens generated $434M in gross profit, $189M in EBITDA, and $73M in net income.
Revenue (LTM)
Exosens P&L
In the most recent fiscal year, Exosens reported revenue of $552M and EBITDA of $179M.
Exosens is profitable as of last fiscal year, with gross margin of 47%, EBITDA margin of 32%, and net margin of 9%.
Financial data powered by Morningstar, Inc.
Exosens Stock Performance
Exosens has current market cap of $4B, and enterprise value of $4B.
Market Cap Evolution
Exosens' stock price is $79.39.
Exosens share price decreased by 0.1% in the last 30 days, and increased by 70.5% in the last year.
Exosens has an EPS (earnings per share) of $0.99.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $4B | -0.1% | -0.1% | 9.8% | 70.5% | $0.99 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialExosens Valuation Multiples
Exosens trades at 6.8x EV/Revenue multiple, and 20.8x EV/EBITDA.
EV / Revenue (LTM)
Exosens Financial Valuation Multiples
As of June 2, 2026, Exosens has market cap of $4B and EV of $4B.
Exosens has a P/E ratio of 55.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Exosens Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Exosens Margins & Growth Rates
Exosens grew revenue by 13% and EBITDA by 14% in the last fiscal year.
In the most recent fiscal year, Exosens reported gross margin of 47%, EBITDA margin of 32%, and net margin of 9%.
Exosens Margins
Exosens Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Exosens Operational KPIs
Exosens' revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Exosens' Rule of 40 is 72% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Exosens' Rule of X is 131% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Exosens Competitors
Exosens competitors include Carel Industries, nLight, MITAC Holdings, RORZE, Infleqtion, GRG Banking, Guangzhou Shiyuan, Accretech, AData Technology Co and EO Technics.
Most Exosens public comparables operate across Computer Hardware, Sensors & Monitoring and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 5.5x | 5.3x | 24.1x | 26.1x | |||
| 14.1x | 13.1x | 157.0x | 119.5x | |||
| 1.1x | 0.8x | 11.8x | 11.4x | |||
| 4.8x | 4.5x | 17.7x | 16.4x | |||
| 118.6x | 95.5x | (92.8x) | (100.5x) | |||
| 1.3x | 1.3x | 10.2x | 14.4x | |||
| 1.1x | 1.1x | 18.2x | 20.5x | |||
| 4.3x | 3.8x | 16.3x | 15.8x | |||
This data is available for Pro users. Sign up to see all Exosens competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Exosens
Exosens has acquired 5 companies to date.
Last acquisition by Exosens was on April 23rd 2026. Exosens acquired Emberion Oy for undisclosed valuation.
Latest Acquisitions by Exosens
| Description | Emberion Oy develops graphene photonics and electronics for infrared photodetectors and thermal sensors in hyperspectral imaging, thermal imaging, night vision, and X-ray detection. | Phasics is a Paris-headquartered manufacturer of Shack-Hartmann wavefront sensors for laser diagnostics and adaptive optics. The company delivers SID4 cameras measuring aberrations down to 0.03 micrometers for beam profiling in high-power fiber lasers. Serving Airbus and ESA projects, Phasics provides quantitative phase imaging modules for microscopy in biotech labs across Europe. | Nightvision Lasers Spain is a Madrid-based manufacturer of night vision optics for military and civilian use. The company produces goggles, monoculars, and clip-on devices using Gen 2+ and Gen 3 image intensifiers fused with thermal imaging. Exported to NATO allies, products feature 64 lp/mm resolution and waterproof housings for operations in Spain, Latin America, and the Middle East. | LR Tech is a Quebec-based designer of instrumentation for atmospheric and infrared remote sensing. Its products include spectrometers, radiometers, and calibration systems used in environmental monitoring and climate research. The company supplies systems to meteorological agencies and research institutes worldwide from its Sainte-Foy facility. | |
| HQ Country | |||||
| HQ City | Espoo | Saint-Aubin | Alcobendas | Quebec City | |
| Deal Date | 23 Apr 2026 | 27 Aug 2025 | 22 Oct 2024 | 2 Sep 2024 | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Exosens acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Exosens
| When was Exosens founded? | Exosens was founded in 2021. |
| Where is Exosens headquartered? | Exosens is headquartered in France. |
| How many employees does Exosens have? | As of today, Exosens has over 1K employees. |
| Who is the CEO of Exosens? | Exosens' CEO is Jerome Cerisier. |
| Is Exosens publicly listed? | Yes, Exosens is a public company listed on Euronext Paris. |
| What is the stock symbol of Exosens? | Exosens trades under EXENS ticker. |
| When did Exosens go public? | Exosens went public in 2024. |
| Who are competitors of Exosens? | Exosens main competitors include Carel Industries, nLight, MITAC Holdings, RORZE, Infleqtion, GRG Banking, Guangzhou Shiyuan, Accretech, AData Technology Co, EO Technics. |
| What is the current market cap of Exosens? | Exosens' current market cap is $4B. |
| What is the current revenue of Exosens? | Exosens' last 12 months revenue is $582M. |
| What is the current revenue growth of Exosens? | Exosens revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Exosens? | Current revenue multiple of Exosens is 6.8x. |
| What is the current EBITDA of Exosens? | Exosens' last 12 months EBITDA is $189M. |
| What is Exosens' EBITDA margin? | Exosens' last 12 months EBITDA margin is 33%. |
| What is the current EV/EBITDA multiple of Exosens? | Current EBITDA multiple of Exosens is 20.8x. |
| What is the current FCF of Exosens? | Exosens' last 12 months FCF is $63M. |
| What is Exosens' FCF margin? | Exosens' last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Exosens? | Current FCF multiple of Exosens is 62.4x. |
| How many companies Exosens has acquired to date? | As of June 2026, Exosens has acquired 5 companies. |
| What was the largest acquisition by Exosens? | None of the M&A deals Exosens has completed have disclosed valuations. |
| What companies Exosens acquired? | Exosens acquired LR Tech, Phasics, Nightvision Lasers Spain, Centronic, and Emberion Oy. |
| In how many companies Exosens has invested to date? | Exosens hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Exosens
Lists including Exosens
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.



